KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Treasury Shares (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Treasury Shares for 17 consecutive years, with $43.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares changed 0.17% to $43.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $43.6 billion, a 0.17% change, with the full-year FY2025 number at $43.6 billion, changed 0.17% from a year prior.
  • Treasury Shares was $887.0 million for Q4 2025 at Bristol Myers Squibb, roughly flat from $887.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $902.0 million in Q4 2023 to a low of $7.0 million in Q3 2021.
  • A 5-year average of $568.8 million and a median of $824.0 million in 2022 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: increased 29.37% in 2022, then dropped 0.25% in 2024.
  • Bristol Myers Squibb's Treasury Shares stood at $31.3 billion in 2021, then rose by 23.54% to $38.6 billion in 2022, then increased by 13.33% to $43.8 billion in 2023, then dropped by 0.25% to $43.7 billion in 2024, then fell by 0.17% to $43.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Treasury Shares are $43.6 billion (Q4 2025), $43.6 billion (Q3 2025), and $43.6 billion (Q2 2025).